Cargando…
A smoking-associated 7-gene signature for lung cancer diagnosis and prognosis
Smoking is responsible for 90% of lung cancer cases. There is currently no clinically available gene test for early detection of lung cancer in smokers, or an effective patient selection strategy for adjuvant chemotherapy in lung cancer treatment. In this study, concurrent coexpression with multiple...
Autores principales: | WAN, YING-WOOI, RAESE, REBECCA A., FORTNEY, JAMES E., XIAO, CHANGCHANG, LUO, DAJIE, CAVENDISH, JOHN, GIBSON, LAURA F., CASTRANOVA, VINCENT, QIAN, YONG, GUO, NANCY LAN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481011/ https://www.ncbi.nlm.nih.gov/pubmed/22825454 http://dx.doi.org/10.3892/ijo.2012.1556 |
Ejemplares similares
-
Hybrid Models Identified a 12-Gene Signature for Lung Cancer Prognosis and Chemoresponse Prediction
por: Wan, Ying-Wooi, et al.
Publicado: (2010) -
MicroRNA, mRNA, and Proteomics Biomarkers and Therapeutic Targets for Improving Lung Cancer Treatment Outcomes
por: Ye, Qing, et al.
Publicado: (2023) -
The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells
por: PACURARI, MARICICA, et al.
Publicado: (2013) -
MicroRNA-Based Discovery of Biomarkers, Therapeutic Targets, and Repositioning Drugs for Breast Cancer
por: Ye, Qing, et al.
Publicado: (2023) -
Expression-Based Diagnosis, Treatment Selection, and Drug Development for Breast Cancer
por: Ye, Qing, et al.
Publicado: (2023)